| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.02B | +3.7% |
| Gross profit | ¥2.07B | — |
| Operating income | ¥1.52B | — |
| Net income | ¥1.30B | +46.0% |
| Gross margin | 34.4% | Net margin 21.6% |
| Revenue Q/Q | -8.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.95B | 65.6% |
| R&D | ¥0.18B | 3.0% |
| SG&A | ¥0.21B | 3.5% |
| Tax & other | ¥0.22B | 3.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中国巨石 ・ 生益科技 ・ 兖矿能源 ・ 复星医药 ・ 南山铝业 ・ 海航控股 ・ 圆通速递 ・ 恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业 ・ 中航机载
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies